Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries.
Company profile
Ticker
MEDP
Exchange
Website
CEO
August Troendle
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Syneos Health • Icon • Incyte • Zymergen • OmniAb • SomaLogic ...
SEC CIK
Corporate docs
Subsidiaries
Delaware Medpace Acquisition, Inc. • Delaware Medpace IntermediateCo, Inc. • Ohio Imagepace, LLC • Ohio Medpace Clinical Pharmacology LLC • Ohio Medpace, Inc. • Ohio Medpace Reference Laboratories LLC ...
MEDP stock data
Analyst ratings and price targets
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
19 May 23
10-Q
2023 Q1
Quarterly report
25 Apr 23
8-K
Medpace Holdings, Inc. Reports First Quarter 2023 Results
24 Apr 23
DEFA14A
Additional proxy soliciting materials
5 Apr 23
DEF 14A
Definitive proxy
5 Apr 23
ARS
2022 FY
Annual report to shareholders
5 Apr 23
8-K
Entry into a Material Definitive Agreement
31 Mar 23
S-3ASR
Automatic shelf registration
14 Feb 23
10-K
2022 FY
Annual report
14 Feb 23
8-K
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Results
13 Feb 23
Transcripts
MEDP
Earnings call transcript
2023 Q1
25 Apr 23
MEDP
Earnings call transcript
2022 Q4
14 Feb 23
MEDP
Earnings call transcript
2022 Q3
25 Oct 22
MEDP
Earnings call transcript
2022 Q2
26 Jul 22
MEDP
Earnings call transcript
2022 Q1
26 Apr 22
MEDP
Earnings call transcript
2021 Q4
15 Feb 22
MEDP
Earnings call transcript
2021 Q3
26 Oct 21
MEDP
Earnings call transcript
2021 Q2
27 Jul 21
MEDP
Earnings call transcript
2021 Q1
27 Apr 21
MEDP
Earnings call transcript
2020 Q4
16 Feb 21
Latest ownership filings
4
August J. Troendle
8 Jun 23
4
Change in insider ownership
8 Jun 23
144
Notice of proposed sale of securities
7 Jun 23
4
Brian T Carley
23 May 23
4
FRED B DAVENPORT JR
23 May 23
4
Femida H. Gwadry-Sridhar
23 May 23
4
Ashley M. Keating
23 May 23
4
Cornelius P. McCarthy III
23 May 23
4
Robert O. Kraft
23 May 23
4
August J. Troendle
27 Apr 23
Financial summary
| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 46.92 mm | 46.92 mm | 46.92 mm | 46.92 mm | 46.92 mm | 46.92 mm |
| Cash burn (monthly) | (no burn) | 2.99 mm | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | n/a | 7.00 mm | n/a | n/a | n/a | n/a |
| Cash remaining | n/a | 39.93 mm | n/a | n/a | n/a | n/a |
| Runway (months of cash) | n/a | 13.3 | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2023
| 13F holders | Current |
|---|---|
| Total holders | 402 |
| Opened positions | 49 |
| Closed positions | 62 |
| Increased positions | 166 |
| Reduced positions | 139 |
| 13F shares | Current |
|---|---|
| Total value | 4.42 tn |
| Total shares | 40.92 mm |
| Total puts | 37.00 k |
| Total calls | 19.60 k |
| Total put/call ratio | 1.9 |
| Largest owners | Shares | Value |
|---|---|---|
| Cinven Capital Management | 10.40 mm | $451.26 mm |
| Troendle August J. | 6.33 mm | $982.14 mm |
| BLK Blackrock | 3.18 mm | $598.33 bn |
| Vanguard | 2.66 mm | $500.29 bn |
| Wasatch Advisors | 1.86 mm | $349.52 bn |
| Fuller & Thaler Asset Management | 939.95 k | $176.76 bn |
| STT State Street | 841.19 k | $158.19 bn |
| Geode Capital Management | 587.94 k | $110.56 bn |
| Boston Trust Walden | 562.64 k | $105.80 bn |
| GS Goldman Sachs | 548.73 k | $103.19 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Jun 23 | Medpace Investors | Common Stock | Sell | Dispose S | No | Yes | 223.05 | 110,324 | 24.61 mm | 6,282,366 |
| 7 Jun 23 | Troendle August J. | Common Stock | Sell | Dispose S | Yes | Yes | 223.05 | 110,324 | 24.61 mm | 6,282,366 |
| 6 Jun 23 | Medpace Investors | Common Stock | Sell | Dispose S | No | Yes | 220.46 | 58,681 | 12.94 mm | 6,392,690 |
| 6 Jun 23 | Troendle August J. | Common Stock | Sell | Dispose S | Yes | Yes | 220.46 | 58,681 | 12.94 mm | 6,392,690 |
| 19 May 23 | Kraft Robert O. | Stock Option Common Stock | Grant | Acquire A | No | No | 210.88 | 1,769 | 373.05 k | 1,769 |
| 19 May 23 | McCarthy Cornelius P. III | Stock Option Common Stock | Grant | Acquire A | No | No | 210.88 | 1,769 | 373.05 k | 1,769 |
| 19 May 23 | Keating Ashley M. | Stock Option Common Stock | Grant | Acquire A | No | No | 210.88 | 1,769 | 373.05 k | 1,769 |
News
10 Health Care Stocks With Whale Alerts In Today's Session
9 Jun 23
Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023
8 May 23
Guggenheim Upgrades Medpace Hldgs to Buy, Announces $252 Price Target
8 May 23
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
25 Apr 23
12 Health Care Stocks Moving In Tuesday's Intraday Session
25 Apr 23